Hospital News and Research

RSS

Study: High-risk emergency surgery poses greater risk for elderly patients

Frailty is a well-established predictor of complications and death after surgery. However, patients over 65 who undergo a high-risk operation in the emergency room are at significantly increased risk of postoperative complications and death in comparison to the same patients who are assessed solely on their level of frailty, according to a study published in the Journal of the American College of Surgeons.

25 Apr 2024

Personalized risk prediction tool helps prioritize high-risk infants for RSV prevention

A new tool to identify infants most at risk for severe respiratory syncytial virus (RSV) illness could aid pediatricians in prioritizing children under 1 to receive a preventive medication before RSV season (October-April), according to Vanderbilt University Medical Center (VUMC) research published in Open Forum Infectious Diseases and to be presented at the American Thoracic Society 2024 International Conference.

25 Apr 2024

Racial disparities found in delayed COVID-19 testing among healthcare workers

At the height of the pandemic, timely access to COVID-19 testing was crucial for curbing the spread of the disease and informing treatment decisions.

25 Apr 2024

Research reveals mortality disparities among sexual minority women

Compared to heterosexual women, bisexual women died 37% sooner and lesbian women 20% sooner, according to results from one of the largest studies to examine sexual orientation-related inequities in mortality and the first to differentiate between lesbians and bisexual women.

25 Apr 2024

Genetically modified mice reveal key players in immune defense against viruses

Chemokines are signaling proteins that orchestrate the interaction of immune cells against pathogens and tumors.

25 Apr 2024

Study illuminates the interplay between health care technologies and essence of compassionate care

Cross Country Healthcare, Inc., a pioneering force in tech-driven workforce solutions and advisory services, in collaboration with Florida Atlantic University's Christine E. Lynn College of Nursing, released its latest research findings in the fourth annual installment of the Future of Nursing Survey: "Embracing Technology While Preserving Humanity."

25 Apr 2024

Imaging using fundus autofluorescence can facilitate the diagnosis and monitoring of rare eye diseases

Uveitis is a rare inflammatory eye disease. Posterior and panuveitis in particular are associated with a poor prognosis and a protracted course of the disease. Diagnosis and monitoring can be challenging for healthcare professionals.

25 Apr 2024

Machine learning system offers new hope for diagnosis of rare genetic disorders

Diagnosing rare Mendelian disorders is a labor-intensive task, even for experienced geneticists. Investigators at Baylor College of Medicine are trying to make the process more efficient using artificial intelligence.

25 Apr 2024

National study links air pollution to increased risk of heart attacks in Poland

Subpopulations at heightened risk for ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI) due to air pollution.

25 Apr 2024

New system personalizes chemotherapy doses for cancer patients

When cancer patients undergo chemotherapy, the dose of most drugs is calculated based on the patient's body surface area. This is estimated by plugging the patient's height and weight into an equation, dating to 1916, that was formulated from data on just nine patients.

24 Apr 2024

Opportunities and limitations of using a large language model to respond to patient messages

A new study by investigators from Mass General Brigham demonstrates that large language models (LLMs), a type of generative AI, may help reduce physician workload and improve patient education when used to draft replies to patient messages.

24 Apr 2024

Research reveals potential target for enfortumab vedotin therapy in urothelial carcinoma

Under the leadership of PD Dr. Niklas Klümper, Assistant Physician at the Department of Urology at the University Hospital Bonn (UKB) and Clinician Scientist of the BMBF-funded ACCENT program and PD Dr. Markus Eckstein, senior physician at the Institute of Pathology at the Uniklinikum Erlangen of the Friedrich-Alexander-University Erlangen-Nürnberg (FAU), an interdisciplinary research team has published new findings that indicate which patients with advanced urothelial carcinoma could benefit in particular from the new targeted therapy with the antibody-drug conjugate enfortumab vedotin.

24 Apr 2024

CASGEVY gene therapy eliminates vaso-occlusive crises in sickle cell patients

In a landmark study, an international consortium led by researchers at Children's Hospital of Philadelphia (CHOP) published the final results of a key clinical trial of the gene therapy CASGEVY (exagamglogene autotemcel) for the treatment of sickle cell disease in patients 12 years and older with recurrent vaso-occlusive crises (VOCs).

24 Apr 2024

Prostaglandin E2: The culprit behind tumor immune evasion

Tumors actively prevent the formation of immune responses by so-called cytotoxic T cells, which are essential in combating cancer. Researchers at the Technical University of Munich (TUM) and the Ludwig-Maximilians-Universität München (LMU) Hospital have now uncovered for the first time how this exactly happens.

24 Apr 2024

Paclitaxel treatment found to directly promote HBV replication and transcription

Hepatitis B virus (HBV) reactivation is commonly observed in individuals with chronic HBV infection undergoing antineoplastic drug therapy.

24 Apr 2024

MSU team creates a promising vaccine candidate for antibiotic-resistant bacteria

Driven by the overuse of antimicrobials, pathogens are quickly building up resistances to once-successful treatments.

24 Apr 2024

Novel immunotherapy shows promise for high-risk sarcomas: HEROS 2.0 trial results published

Researchers at Texas Children’s Cancer Center and the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children’s Hospital and Houston Methodist published results of a phase I clinical trial of a novel immunotherapy for high-risk sarcomas in the journal Nature Cancer.

24 Apr 2024

Advanced insulin pumps enhance blood sugar management in type 1 diabetes

Previous
1
...
7
8
9
10
11
12
13
...
4021
Next

Hospital News and Research

Study: High-risk emergency surgery poses greater risk for elderly patients

Personalized risk prediction tool helps prioritize high-risk infants for RSV prevention

Racial disparities found in delayed COVID-19 testing among healthcare workers

Research reveals mortality disparities among sexual minority women

Genetically modified mice reveal key players in immune defense against viruses

Study illuminates the interplay between health care technologies and essence of compassionate care

Imaging using fundus autofluorescence can facilitate the diagnosis and monitoring of rare eye diseases

Machine learning system offers new hope for diagnosis of rare genetic disorders

National study links air pollution to increased risk of heart attacks in Poland

New system personalizes chemotherapy doses for cancer patients

Opportunities and limitations of using a large language model to respond to patient messages

Research reveals potential target for enfortumab vedotin therapy in urothelial carcinoma

CASGEVY gene therapy eliminates vaso-occlusive crises in sickle cell patients

Prostaglandin E2: The culprit behind tumor immune evasion

Paclitaxel treatment found to directly promote HBV replication and transcription

MSU team creates a promising vaccine candidate for antibiotic-resistant bacteria

Novel immunotherapy shows promise for high-risk sarcomas: HEROS 2.0 trial results published

Advanced insulin pumps enhance blood sugar management in type 1 diabetes

Anesthetic midazolam boosts survival after cardiac arrest

Global study reveals mismatch in COVID-19 treatment guidelines with WHO standards

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News